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ABSTRACT
Background: A woman’s risk for cervical cancer has been used by physicians to guide the ini-
tiation and frequency of a Pap smear. The aim of this study was to determine family physi-
cians’ knowledge of risk factors for cervical cancer and perceived importance of risk in screen-
ing women.
Methods: The self-administered questionnaire was mailed to 5000 randomly selected active
members of the American Academy of Family Physicians (AAFP).
Results: Data from 2748 usable questionnaires indicated the mean number of risks consid-
ered for cervical cancer was 4.5. Physician’s age and the number of reported risks were in-
versely correlated (p 5 0.0001). Female physicians reported significantly more risk factors than
male physicians (p 5 0.05). The number of Pap smears performed per month was positively
correlated with the number of risk factors reported (p 5 0.001). Only 10% of the physicians
indicated that they perform a Pap smear at the same interval regardless of the risk of the wo-
man.
Conclusions: This sample of family physicians has a limited understanding of the risk fac-
tors for cervical cancer. This was true regardless of the age, gender, training, race, geographic
location, or practice setting of the responding physician. Yet the usual practice of screening
for cervical cancer reported by these physicians would suggest that knowledge and use of
risk factors would be a critical aspect of screening for cervical cancer.
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INTRODUCTION
IN 1941, EXFOLIATIVE CERVICAL CYTOLOGY was in-troduced by Papanicolaou and Traut1 as a
method for the early diagnosis of “carcinoma of
the female genital tract.” Since its introduction as
a vaginal pool aspiration, the Pap smear has
rapidly evolved through a broad spectrum of
techniques and protocols,2–4 with wide accep-
tance by physicians. Although no definitive ran-
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domized, control led trial has been done to de-
termine efficacy of this screening procedure in 
reducing morbidity and mortality, a number of
studies have indirectly demonstrated efficacy by
reporting a decrease in the incidence of invasive
cervical carcinoma associated with increased
screening.5–11 Studies continue to show mass Pap
smear screening to result in early detection and
treatment with a marked decline in mortality
rates.12
A number of single steps within cervical can-
cer screening are critical to maintaining a highly
efficacious screening program. The physician’s
role is central to the process, as emphasized by
several professional organizations.13–15 As a wo-
man’s risk for cervical cancer changes, so do the
recommendations for when to initiate screening
and how frequently to screen. Medicare provides
coverage for a Pap smear and pelvic examination
once every 24 months. If a woman is at high risk
for cervical or vaginal cancer, Medicare covers
these tests every 12 months. The American Can-
cer Society (ACS) currently recommends that all
women begin yearly Pap tests within 3 years of
vaginal intercourse, but no later than age 21.16
Screening should be annual until age 30. Starting
at age 30, women who have had three consecu-
tive, technically satisfactory, normal/negative cy-
tology tests may increase the interval to every 2–3
years.16 Previously, the ACS recommended that
if a woman had three negative annual Pap tests
in a row, this test could be done less often at the
judgment of the woman’s health care profes-
sional.13 This judgment hinges on the risk to the
woman. Therefore, being able to estimate a wo-
man’s level of risk is valuable in the screening
process for cervical cancer. Despite the tens of
millions of Pap smears done annually, it is un-
known whether physicians are able to make an
accurate assessment of a woman’s risk for cervi-
cal cancer.
The study objectives were to determine which
risk factors for cervical cancer are considered by
family physicians and what importance they at-
tach to each risk factor in screening women. In
addition, the study sought to determine family
physicians’ perceptions of the percentage of wo-
men in their practice at increased risk for cervi-
cal cancer. This study was conducted in 1995,
when the recommendations for the interval for
Pap smear screening were based on the risk to
the woman.
MATERIALS AND METHODS
A self-administered questionnaire was devel-
oped and modified based on a series of pilot stud-
ies. The final questionnaire used in this study 
consisted of 44 closed-ended questions and 2
open-ended questions. To facilitate completion,
the questionnaire was sequenced to follow the
steps in collecting a Pap smear.17 The reliability
was determined for each item of the question-
naire using kappa statistics for categorical data
and correlation coefficients for continuous data.
The reliability was excellent, with kappa statistic
range .75–.90 and correlation coefficient range
.83–.90, with all 50 physicians completing the
questionnaire each time.
The format for accessing physicians’ knowl-
edge of risk factors for cervical cancer was a state-
ment that the medical literature suggests there are
as many as 10 identifiable risk factors. Ten slots
were provided along with a scale next to each slot
for physicians to rate the importance of the risk
factor in their decision on when to start and how
often to screen for cervical cancer. The scale was
a 5-point scale from 1 (minimal importance) to 5
(very important). In the pilot studies of 300 physi-
cians, the number of risk factors reported ranged
from 3 to 10 evidence-supported risk factors, with
only 10 risk factors that were not supported by
evidence. The number of risk factors reported, the
specific risk factor listed, and the importance rat-
ing of each risk factor did not change with re-
peated completion of the survey.
The self-administered questionnaire was
mailed with a cover letter that included an intro-
duction of the project, quotes from nationally rec-
ognized leaders in family practice supporting the
study, and an envelope with return postage. The
nonresponders were mailed reminders at 2 and 4
weeks after the first mailing. At 6 weeks, another
survey and second cover letter were mailed to
nonrespondents. This was followed by mailed re-
minders 2 and 4 weeks later. The final group of
nonresponders was contacted by telephone to de-
termine if the physician was still in practice and
if that physician saw women and screened for
cervical cancer.
The study sample was 5000 randomly selected
active members of the American Academy of
family physicians (AAFP). Active members are
practicing physicians or full-time teachers of fam-
ily practice who are graduates of a school of med-
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icine. These members are required to report 150
hours of AAFP-approved continuing medical ed-
ucation credits every 3 years. The total popula-
tion at the time of sampling was 38,095 active
members, with 33,141 men and 4,950 women.
The physicians’ responses relevant to research
questions were examined in terms of percent dis-
tribution and means to describe the group. Com-
parisons between different groups were done
with appropriate chi-square, t test univariate
comparisons, or correlation (zero-order and par-
tial). The variables used to determine groups for
comparisons were physician’s gender, residency
training status, and number of Pap smears per-
formed per month.
RESULTS
The responses to the mailed physicians’ survey
were 3551 (71%) with 2748 (55%) usable ques-
tionnaires. The reasons for excluding the 803 re-
sponses were cervical cancer screening not part
of their clinical practice (466, 58%), physician no
longer involved in patient care (249, 31%), and
physician no longer alive (88, 11%). No difference
was found between respondents (3551) and non-
respondents (1449) by age (mean age 44.8 years
vs. 49.1 years) and gender (male 82.7% vs. 85.2%
female). Of the 1449 nonresponders, 800 were
reached by telephone. Among these 800 physi-
cians, 384 (48%) did not see women, 240 (30%)
did not screen for cervical cancer in their prac-
tice, 96 (12%) had moved to another practice lo-
cation, and 80 (10%) were no longer in clinical
practice. No other information was available on
the nonresponders for comparison. Demographic
features of the responding physicians are shown
in Table 1.
The average number of Pap smears performed
monthly is shown in Table 2, along with the av-
erage number of patient visits per month by gen-
der of the provider. Male family physicians re-
port seeing significantly more patients on average
each month (p , 0.00001), whereas female family
physicians report performing significantly more
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TABLE 1. DEMOGRAPHIC FEATURES OF RESPONDENTS WITH USABLE RESPONSES (n 5 2748)
Feature Men Women
Number (%) 2273 (82.7) 449 (16.3)
Mean age, years (SD) 45.8 (11.3) 39.4 (8.9)
Training, number (%)
Internship only 555 (24.5) 38 (8.5)
1–3 years FP residency 322 (58.5) 4345 (77.4)
Other 385 (17.1) 63 (14.1)
Board-certified, number (%) 1958 (86.7) 392 (87.3)
Years in practice, number (%)
1–5 543 (24.0) 203 (45.7)
6–11 543 (24.0) 145 (32.5)
12–15 354 (15.7) 52 (11.7)
16–20 151 (6.7) 18 (4.0)
.20 669 (29.6) 27 (6.1)
Type of practice, number (%)
Solo 762 (34.1) 90 (20.5)
Two-person 273 (12.2) 54 (12.3)
$3 family practice 610 (27.3) 103 (23.5)
$3 multispecialty 271 (12.1) 73 (16.6)
Combination 129 (5.8) 37 (8.4)
Other 191 (8.5) 82 (18.7)
Professional activities: mean % time (SD)
Office patient care 76.7 (22.9) 77.5 (24.9)
In-hospital patient care 11.5 (11.3) 8.4 (10.3)
Other patient care 2.1 (8.4) 2.1 (10.5)
Teaching 3.2 (9.5) 4.6 (11.0)
Administration 3.7 (10.8) 3.9 (10.9)
Research 0.5 (3.5) 0.9 (6.1)
Other activities 1.1 (5.9) 1.7 (9.1)
Pap smears on average each month (p , 0.00001),
even after adjusting for part-time status.
Only 10% of the physicians indicated that they
perform a Pap smear at the same interval re-
gardless of the risk of the woman. Response to
this question did not differ significantly based on
physician characteristics, number of risk factors
listed, listing a risk factor that is not evidence sup-
ported, number of Pap smears performed per
month, or perception of percent of women in
practice at increased risk for cervical cancer.
The percent of respondents listing one of the
primary risk factors for cervical cancer is and the
mean importance score assigned for each risk fac-
tor are shown in Table 3. The mean number of
risks reported by physicians was 4.5 6 1.9. Physi-
cian’s age and the number of reported risks were
significantly inversely correlated (p 5 0.0001). Fe-
male physicians reported significantly more risk
factors than male physicians (5.3 6 1.2 vs 3.1 6
1.3, p 5 0.05). The number of Pap smears per-
formed per month was positively correlated with
the number of risk factors reported (p # 0.001).
These relationships were the same if the number
of risks reported was restricted to primary risk
factors. No other physician characteristics were
related to risk reported, number of risks reported,
or the importance of each risk.
The response category of Other (Table 3) con-
tains identified risks not found to be supported
by current medical literature. Of the respondents,
1927 identified 90 other risk factors for cervical
cancer. The top 8 other responses were family his-
tory of cervical cancer (905, 33%), age (316, 11%),
in utero diethylstilbestrol exposure (304, 11%),
number of pregnancies (273, 10%), oral contra-
ceptive use (251, 9%), uncircumcised male part-
ner (244, 9%), race (220, 9%), and low socioeco-
nomic status (199, 7%).
Physicians’ reported perception of the percent
of women at increased risk for cervical cancer in
their practice ranged from 0% to 100%, with a
mean of 26%. Seventy percent of physicians re-
ported that 20% or less of their female patients
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TABLE 2. DISTRIBUTION OF REPORTED AVERAGE NUMBER OF PAP SMEARS PER MONTH
AND AVERAGE NUMBER OF PATIENTS PER MONTH BY GENDER OF PROVIDER
Average number Men Women Average number Men Women
of Pap smears (n 5 2261) (n 5 447) of patient visits (n 5 2259) (n 5 445)
per month % % per month % %
1–10 20.1 12.3 1–100 6.7 9.9
11–20 33.8 16.6 101–200 4.1 19.6
21–30 22.8 17.2 201–300 12.8 24.3
31–40 11.1 18.8 301–400 24.2 19.6
41–50 6.9 14.1 401–500 24.4 16.2
51 or more 4.5 21.0 501 or more 17.8 10.6
p , 0.00001 p , 0.00001
TABLE 3. NUMBER AND PERCENT OF RESPONDERS IDENTIFYING EVIDENCE-SUPPORTED RISK FACTORS
FOR CERVICAL CANCER AND MEAN IMPORTANCE SCORE GIVEN THIS RISK (n 5 2748)
Number % Mean importance score
Multiple partners 2167 79 4.2
Early age intercourse 1440 52 3.8
Human papillomavirus 564 20 4.5
Frequent sexually transmitted disease 758 28 3.9
Herpes simplex virus 848 31 3.9
Abnormal Pap smear 497 18 4.6
Smoking 564 21 2.9
Poor screening compliance 57 2 4.0
Partner with multiple partners 55 2 3.8
Sexually active 144 5 3.9
Othera 1927 70 —
aThis category contains risk factors identified by physicians but not supported in the medical literature.
were at increased risk for cervical cancer. Female
physicians were significantly more likely than
male physicians to report their practice as having
a higher percentage of women at increased risk
for cervical cancer (31% vs. 22%, p , 0.000001).
DISCUSSION
This sample of family physicians from across
the country has a limited understanding of the
risk factors for cervical cancer. This was true re-
gardless of the age, training, race, geographic lo-
cation, practice setting, or the reported risk of
their practice population of the responding physi-
cian. Female physicians and physicians perform-
ing more Pap smears (regardless of gender) on
average per month are aware of more of the risk
factors but not enough to risk-assess woman for
cervical cancer. Numerous risks for cervical can-
cer were reported that have not been supported
or have not been addressed in the published lit-
erature.
If risk assessment for cervical cancer is critical
to initiating the screening process as well as de-
ciding on the interval at which to screen,18,19
there are several well-established risks that
should be used. The risk factors supported by the
medical literature are early age of initiating sex-
ual intercourse,20–22 multiple partners20,22–25 a
sexual partner with multiple partners,23,26–28 hu-
man papillomavirus,29,30 herpes virus,20,31 atypia
or dysplasia,32,33 frequent sexually transmitted
diseases,23,26–28 smoking of cigarettes,34–41 and
poor screening compliance.42–44 In this sample of
family physicians, the number of reported risk
factors considered was relatively low, along with
many other risks being identified.
Some of the risk factors identified by the re-
spondents that lack published evidence may re-
flect misunderstanding of risk factors or physi-
cians using their own experience. For example,
race and low socioeconomic satus may repre-
sent characteristics of women in a physician’s
practice who initiate sexual intercourse at an
early age, have multiple sexual partners, and
smoke. Race and low socioeconomic status are
not the risk but are easier identifiers on which
physicians can focus their attention and screen-
ing efforts. In utero diethylstilbestrol exposure
places a woman at risk for a clear-cell cervical
and vaginal cancer.45,46 This risk does not alter
the time to initiate or how often to screen for
cervical cancer. The risk alters where and how
to screen.
Some would question if it is of any importance
to know whether family physicians can risk-as-
sess women to reduce the interval of screening.19
The current guidelines from the ACS have re-
moved any assessment of risk.16 It has been esti-
mated that screening women aged 20–64 every 3
years with a Pap smear reduces the cumulative
incidence of invasive cervical cancer by 91%. An-
nual screening reduces the incidence by 93%, but
at a substantial increased cost, use of resources,
and patient anxiety.47 This has been confirmed
with population-based data.48 Thus, it would ap-
pear that it does not matter whether one screens
every year or every 3 years, regardless of the risk
of the woman, yet many gynecologists recom-
mend a Pap smear at least once a year.49 Even
among this study population, only 10% did not
consider risk in establishing a frequency for Pap
smear. So the usual practice and opinion of this
sample of physicians would suggest that knowl-
edge and use of risk factor are a critical aspect of
screening for cervical cancer.
Assessing this information was difficult, as dis-
covered in the pilot phase of the instrument de-
velopment. In the pilot phase, physicians could
easily identify evidence-supported risk factors
from a list of possible risks. However, a telephone
interview of these physicians did not confirm that
the physicians were cognitively fluent with these
risk factors. During the telephone interview,
many physicians noted they were not sure about
the risk factors, but they used their test taking ex-
perience to eliminate “false” risk factors and iden-
tify “true” risk factors. In an attempt to provide
the family physicians with more structure, the
question was revised to what the medical litera-
ture suggests as many as 10 identifiable risk fac-
tors. Even with this approach, the mean number
of risk factors listed was only 4.5. In addition,
over 70% of the respondents listed risk factors
that have not been supported in the medical lit-
erature. The listing of other risk factors may have
been driven by the question format, which pro-
vided space for 10 answers. This misunderstand-
ing of risk for cervical cancer is not unique to this
sample. From a survey of 200 general practition-
ers in Australia, 50% of the respondents incor-
rectly reported they would screen a woman for
cervical cancer who had never been sexually ac-
tive.50
The primary limitation to this study is the re-
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liance on self-reported behavior and assessment
of knowledge. Physicians in this study may in re-
ality not vary their screening interval for Pap
smear on the basis of a woman’s risk. Their ac-
tual application of cervical cancer risk factor may
be more accurate than assessed. However, one
would anticipate their responses to overestimate
and not underestimate their abilities. The re-
sponse rate was acceptable, and nonresponders
seem very unlikely to differ in knowledge or
practices from responders.
Should actions be taken to remedy this knowl-
edge deficit among family physicians? If more
family physicians were aware of the risk for cer-
vical cancer, would more women be adequately
screened for cervical cancer? This study does not
address this issue. Given the low level of knowl-
edge by family physicians and the increasing per-
cent of women adequately screened for cervical
cancer,51,52 it appears not to be a high priority to
address. Promoting the new guidelines for cervi-
cal cancer screening may be far more effective at
eliminating cervical cancer than any campaign to
increase physicians knowledge about risk factors
for cervical cancer.
CONCLUSIONS
The majority of the respondents believe that
risks are important in initiating screening and es-
tablishing a screening interval. However, their re-
sponses suggest that they cannot accurately risk
assess women for cervical cancer. This sample of
family physicians had very limited knowledge of
risk for cervical cancer. If a woman’s risk for cer-
vical cancer is critical to the success of cervical
cancer screening, further research needs to ex-
plore if physicians actually use their risk assess-
ment in making the decision to initiate screening
or in establishing a screening interval. The cur-
rent recommendations for screening for cervical
cancer that remove risk assessment are more
likely to be implemented and accepted.
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